LBRDP vs REGN · P/E 4.6, rev $1.02B vs P/E 14, rev $4.29B
Liberty Broadband Corp (LBRDP) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Liberty Broadband Corp (LBRDP) is a telecom services company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported LBRDP revenue for 2024-12-31 was $1.02B. Net income was $869.0M. Revenue was up 3.6% from 2023-12-31 to 2024-12-31. LBRDP currently screens at market cap $0 and trailing P/E 4.6.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
LBRDP currently screens at market cap $0 and trailing P/E 4.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the LBRDP and REGN stock pages for the full models.
Not investment advice.